Streetbeat News

MEDIF

Medipharm Labs Corp

https://ir.medipharmlabs.com/

Industry

Medicinal and Botanical Manufacturing

Open

0.06

Mkt cap

24M

Volume

500

High

0.06

P/E Ratio

-2.00

52-wk high

0.07

Low

0.06

Div yield

N/A

52-wk low

0.04

MediPharm Labs Corp. has received GMP certification from ANVISA for its facility in Barrie, Ontario, enabling it to produce medical cannabis products for the Brazilian market. This adds to its existing certifications from the FDA, EU, Australia's TGA, and Health Canada. The Brazilian medical cannabis market is expected to reach $281.2 million by 2025. MediPharm has two products with full ANVISA authorization and is reviewing additional products. It also has a supply agreement with a Brazilian pharmaceutical company and a partnership with a Rio distributor. MediPharm's shares rose 2.6923% to $0.0534 after the announcement.

Portfolio Pulse from Jelena Martinovic

February 07, 2024 | 4:05 pm

The cannabis industry is experiencing significant leadership changes as we head into 2024. The Indigenous Cannabis Industry Association (ICIA) hosted a roundtable to discuss hemp and cannabis regulation. Emerald Holding, Inc. (NYSE:EEX) promoted Emilie Lewis to oversee marketing for Marijuana Business Daily. MediPharm Labs Corp. (OTCQB:MEDIF) announced the resignation of board member Miriam McDonald. Lowell Farms Inc. (OTCQX:LOWLF) reported the departure of board member Brian Shure. Trulieve Cannabis Corp. (OTCQX:TCNNF) named Wes Getman as its new CFO, and Organigram Holdings Inc. (NASDAQ:OGI) appointed Greg Guyatt as CFO. Innocan Pharma Corporation (OTCQB:INNPF) established a team for FDA submission for its LPT CBD platform.

Portfolio Pulse from Jelena Martinovic

December 22, 2023 | 9:31 pm

MediPharm Labs Corp. reported Q3 2023 financial results with revenue of C$8.5 million, a sequential decrease but a year-over-year increase. The company saw its highest gross profit since Q4 2019 at C$2.4M and improved adjusted EBITDA. Integration of VIVO led to significant savings, and a strong balance sheet was noted with C$13M in cash. A dispute settlement with Tilray Brands, Inc. resulted in C$9M for MediPharm, including cash, products, and a purchase agreement. MediPharm's stock (MEDIF) traded down 2.23% on the news.

Portfolio Pulse from Joana Scopel

November 14, 2023 | 7:21 pm

Several new cannabis products have been introduced to the global health and wellness market. Cornbread Hemp has launched the first USDA-certified organic CBD Sleep Gummies. UCG Inc. has partnered with Mana Supply to introduce the Dabstract brand to Missouri's recreational cannabis market. Earthy Select has expanded its premium THCa flower product line. MediPharm Labs Corp. has introduced GMP-certified Beacon Medical cannabis products into the Australian medical market.

Portfolio Pulse from Joana Scopel

October 16, 2023 | 1:48 pm

MediPharm Labs Corp. has settled a commercial agreement dispute with Tilray's Hexo for $9 million. The dispute was over a long-term supply agreement for cannabis concentrates. As part of the settlement, Hexo will abandon its appeal against MediPharm. The settlement includes a $3 million immediate cash payment, $4.5 million in Tilray common shares, $1 million in Tilray cannabis products, and a $500,000 supply agreement to provide Tilray with MediPharm products and services over four years.

Portfolio Pulse from Nina Zdinjak

October 02, 2023 | 1:49 pm

MediPharm Labs Corp. has announced the launch of Canadian-produced GMP Beacon Medical cannabis oil and inhalation cartridges in the Australian medical marijuana market. The products include a high CBD Isolate oil, a balanced oil, and a THC dominant full spectrum oil. The company has started shipping inhalation cartridges to patients and plans to ship cannabis oils from Canada this week. MediPharm holds an Australian GMP license from the Therapeutic Goods Administration (TGA), complemented by its GMP status from Health Canada and the US FDA.

Portfolio Pulse from Jelena Martinovic

September 28, 2023 | 11:57 pm

MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) has ended its royalty agreement with Shelter Cannabis for the Shelter Cannabis Brands IP portfolio. The supplementary agreement will improve the product line's gross margin, allowing MediPharm to invest more in the brand. MediPharm will continue to review its product categories and selling channels to optimize margins and streamline operations. The company's shares traded 1.35% higher at $81.99 per share during the pre-market session on Wednesday.

Portfolio Pulse from Jelena Martinovic

September 20, 2023 | 1:42 pm

The article lists the cannabis stocks that gained and lost on August 24, 2023. Notable gainers include EVIO, Red White & Bloom Brands, and CBD Unlimited. Major losers include Choom Holdings, Radient Technologies, and Target Group.

Portfolio Pulse from Benzinga Insights

August 24, 2023 | 9:30 pm

On August 23, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Hemp (OTC:HEMP), 1933 Industries (OTC:TGIFF), and SLANG Worldwide (OTC:SLGWF), while notable losers included Red White & Bloom Brands (OTC:RWBYF), Heritage Cannabis Holding (OTC:HERTF), and CordovaCann (OTC:LVRLF).

Portfolio Pulse from Benzinga Insights

August 23, 2023 | 9:30 pm

The article lists the cannabis stocks that gained and lost on August 16, 2023. The biggest gainers were Red White & Bloom Brands, Target Group, and Khiron Life Sciences, while the biggest losers were EVIO, Tetra Bio Pharma, and Heritage Cannabis Holding.

Portfolio Pulse from Benzinga Insights

August 16, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.